Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in the U.S.
COPD is a chronic inflammatory lung disease that obstructs airflow from the lungs and causes breathing problems. Tiotropium Bromide treats...
Singapore-based medtech Aevice Health has received undisclosed funding from venture capitalist East Ventures for its expansion in Southeast Asia.
It has also announced that its flagship product, the smart wearable stethoscope AeviceMD, has been given a 510(k) clearance by the United States Food and Drug Administration.
AeviceMD is part of the AeviceMD Monitoring System, a patient management...
Wellinks, the company behind a digital platform and connected devices for chronic obstructive pulmonary disease, has appointed Stacie Bratcher as CEO, filling the position left vacant by Alex Waldron in March.
The Connecticut-based company offers a platform to track COPD treatments, symptoms and vitals, coaching and pulmonary rehab, and connected devices like nebulizers and pulse oximeters....
Respiree, a med tech spinoff of Singapore's Agency for Science, Technology and Research, has obtained the United States Food and Drug Administration's 510(k) clearance for its wearable cardio-respiratory sensor device.
The RS001 device directly measures respiration in patients dealing with cardio-pulmonary diseases such as COPD and congestive heart failure.
It is part of Respiree's iRIS...
LifeSemantics teases pulmonary rehabilitation DTx
South Korean digital health company LifeSemantics is launching its digital therapeutics product that helps with the pulmonary rehabilitation of people with COPD.
The Redpill Breath DTx helps users self-rehabilitate their respiratory functions at home. It monitors their oxygen saturation and walking performance in real time, sends text alerts in...
Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with GlaxoSmithKline’s range of Ellipta dry powder inhalers.
The ASX-listed firm offers the Hailie sensor which attaches to an inhaler to remotely monitor and capture medication usage parameters and...
Wellinks, the company behind a digital platform and connected devices for chronic obstructive pulmonary disease, raised $25 million in Series C funding.
The round was led by Morningside Ventures with participation from HighCape Capital, Connecticut Innovations, Benslie Ltd. and Stonehenge Capital.
The Series C builds on a $14 million Series B raise from 2019.
WHAT IT DOES
Wellinks, formerly...
NHS-approved digital therapeutics company, my mhealth, along with three European collaborators, have been awarded a €2.5 million Eurostars Grant for the development of their project, CUOREMA.
Eurostars is a European joint programme, co-funded from the national budgets of 36 EUREKA countries and by the European Union through Horizon 2020. Innovate UK will also sponsor my mhealth to develop part of...
New York-based Kaia Health has completed a €62 million ($75m) Series C funding round to expand clinical capabilities and treatment services for Musculoskeletal (MSK) and Chronic obstructive pulmonary disease (COPD) care in the US and Europe.
The total raised to date is €103 million ($125m), and was led by an unnamed growth equity fund with support from existing investors, including Optum Ventures...
NowPow, a community referral network seeking to address social determinants of health, has partnered with the Chicago Department of Public Health (CDPH) to strengthen its local digital infrastructure and extend the department's contact tracing reach.
In addition to using NowPow's platform to understand which resources a quarantined individual may need and connecting them to supportive services,...
